18October

Semaglutide receives positive 16-0 vote in favour of approval from FDA Advisory ... Read more

16October

Novo Nordisk: FDA posts briefing materials prior to Advisory Committee meeting f ... Read more

29September

Novo Nordisk's new fast-acting mealtime insulin Fiasp® approved in the US ... Read more

29September

CHMP endorses Tresiba® label update in the EU - new label reflects significant r ... Read more

18October

Semaglutide receives positive 16-0 vote in favour of approval from FDA Advisory ... Read more

16October

Novo Nordisk: FDA posts briefing materials prior to Advisory Committee meeting f ... Read more

16October

Novo Nordisk A/S - Share repurchase programme ... Read more

09October

Novo Nordisk A/S - Share repurchase programme ... Read more

01November

Financial statement for the first nine months of 2017,

07November

Societe Generale European ESG/SRI Conference, Paris

23November

HSBC Healthcare Conference, Frankfurt

28November

Dansk Aktionærforening - InvestorDagen, Vejle

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
Capital Markets Day 2017 


Click here to find further information

 
Semaglutide AdCom


Semaglutide AdCom conference call and roadshow presentation



Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



IR material


Download relevant Investor Relations material



Contacts



Subscriptions


Sign up to receive company announcements.


LEADER AdCom